학술논문
The clinical effects of inclisiran, a first-in-class LDL-C lowering siRNA therapy, on the LDL-C levels in Chinese patients with hypercholesterolemia
Document Type
Article
Author
Source
In Journal of Clinical Lipidology May-June 2023 17(3):392-400
Subject
Language
ISSN
1933-2874